CRX Is a Diagnostic Marker of Retinal and Pineal Lineage Tumors

Sandro Santagata; Cecile L. Maire; Ahmed Idbaih; Lars Geffers; Mick Correll; Kristina Holton; John Quackenbush; Keith L. Ligon

doi:10.1371/journal.pone.0007932

Loading metrics

Open Access

Peer-reviewed

Research Article

CRX Is a Diagnostic Marker of Retinal and Pineal Lineage Tumors

Sandro Santagata,

Affiliations Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Department of Pathology, Children's Hospital Boston, Boston, Massachusetts, United States of America, Department of Pathology, Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Cecile L. Maire,

Affiliations Department of Pathology, Harvard Medical School, Boston, Massachusetts, United States of America, Department of Medical Oncology and Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
⨯
Ahmed Idbaih,

Affiliations Department of Pathology, Harvard Medical School, Boston, Massachusetts, United States of America, Department of Medical Oncology and Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
⨯
Lars Geffers,

Affiliation Department of Genes and Behavior, Max-Planck-Institute of Biophysical Chemistry, Goettingen, Germany
⨯
Mick Correll,

Affiliation Center for Cancer Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
⨯
Kristina Holton,

Affiliation Center for Cancer Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
⨯
John Quackenbush,

Affiliation Center for Cancer Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
⨯
Keith L. Ligon

* E-mail: keith_ligon@dfci.harvard.edu

Affiliations Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Department of Pathology, Children's Hospital Boston, Boston, Massachusetts, United States of America, Department of Pathology, Harvard Medical School, Boston, Massachusetts, United States of America, Department of Medical Oncology and Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
⨯

CRX Is a Diagnostic Marker of Retinal and Pineal Lineage Tumors

Sandro Santagata,
Cecile L. Maire,
Ahmed Idbaih,
Lars Geffers,
Mick Correll,
Kristina Holton,
John Quackenbush,
Keith L. Ligon

Published: November 20, 2009
https://doi.org/10.1371/journal.pone.0007932

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Germ cell cancer
Is the Subject Area "Germ cell cancer" applicable to this article?

Thanks for your feedback.
Cancer detection and diagnosis
Is the Subject Area "Cancer detection and diagnosis" applicable to this article?

Thanks for your feedback.
Retina
Is the Subject Area "Retina" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Renal cancer
Is the Subject Area "Renal cancer" applicable to this article?

Thanks for your feedback.
Medulloblastoma
Is the Subject Area "Medulloblastoma" applicable to this article?

Thanks for your feedback.
Retinoblastoma
Is the Subject Area "Retinoblastoma" applicable to this article?

Thanks for your feedback.